Evidence map›Paper›PMID 42200796›Full record

ArticleRadiology. Artificial intelligence2026

AI as a Safety Net Reader for Mammograms Classified as Normal or Benign in the French Screening Program.

Christophe Tourasse, Benoît Mesurolle, Maud Ottavy, Patricia Soler-Michel, Patrice Taourel

Abstract read
PubMed Publisher
In one paragraph

Article in Radiology. Artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Christophe TourasseCentre d'imagerie médicale, Imagerie Hôpital Privé Mermoz, 55 Avenue Jean Mermoz, 69008 Lyon, France.ORCID 0000-0001-7377-470X
Benoît MesurolleCentre Radiologie République, Clermont-Ferrand, France.ORCID 0000-0003-4610-9995
Maud OttavyCentre Régional de Coordination des Dépistages des Cancers en Auvergne Rhône-Alpes, Lyon, France.
Patricia Soler-MichelCentre Régional de Coordination des Dépistages des Cancers en Auvergne Rhône-Alpes, Lyon, France.ORCID 0000-0002-8945-2374
Patrice TaourelMedical Imaging Department, CHU Montpellier, Montpellier, France.ORCID 0000-0001-6465-1919

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the French national breast cancer screening program, second reading is performed only for mammograms interpreted as negative (Breast Imaging and Reporting Data System [BI-RADS] 1-2) at first reading, representing a unique screening workflow in Europe. This retrospective study assessed whether artificial intelligence (AI) could identify a subgroup of negative screening mammograms that could safely bypass second reading. A total of 55 589 screening mammograms from 42 419 women aged 50-74 years (January 2015-December 2019) whose mammograms were initially classified as BI-RADS 1-2 were analyzed. Second reading outcomes were compared with those of a commercial AI system using a predefined binary threshold (≥5). Among these examinations, 183 of 55 589 (0.33%) were recalled at second reading, yielding 12 cancers (positive predictive value, 6.6%; cancer detection rate, 0.22 per 1000 examinations). AI classified 42 606 of 55 589 (76.6%) examinations as low risk (≤4) and 12 983 of 55 589 (23.3%) as nonlow risk (≥5). One cancer was detected in the AI-low group (one of 55 589 [0.002%]) compared with 11 in the AI-nonlow group (11 of 55 589 [0.020%];

Indexed as

Artificial IntelligenceBreast NeoplasmsEarly Detection of CancerMammographyAgedBreastFemaleFranceHumansIntelligent SystemsMass ScreeningMiddle AgedRetrospective StudiesBreastComputer Aided Diagnosis (CAD)Mammography

Identifiers

PMID42200796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.